# Fluorescence Guided Focal Cortical Dysplasia Surgery

> **NCT07657975** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 5 (estimated)

## Conditions studied

- Drug Resistant Epilepsy

## Interventions

- **DRUG:** 5-ALA (Gliolan)

## Key facts

- **NCT ID:** NCT07657975
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2028-09
- **Final completion:** 2028-09
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2026-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657975, "Fluorescence Guided Focal Cortical Dysplasia Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07657975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*